2025 Scientific Sessions

Cardio-Oncology Session 1

Interventional Onco-Cardiology – Year in Review
Konstantinos Marmagkiolis, MD, MBA, FSCAI, Tampa General Hospital, Wesley Chapel, FL
CTO’s in Cancer Patients: More Risk, More to Gain, a lot of CHIPS
Salman A. Arain, MD, FSCAI, UTHealth-McGovern Medical School, Houston, TX
IVUS-Guided PCI: A Must in Patients with Cancer and Coronary Artery Disease
Teodora Donisan, MD, Mayo Clinic College of Medicine and Science, Rochester, MN
DCB: Have we Found the Perfect fix for the Refractory Radiation Induced Heard Disease?
Cezar A. Iliescu, MD, FSCAI, The University of Texas MD Anderson Cancer Center, Houston, TX
Indications for TMVR in Cancer Patients
Mehmet Cilingiroglu, MD, FSCAI, Mehmet Cilingiroglu, MD, Inc. , San Diego, CA
Why, When, and how to TAVI Cancer Patients
Konstantinos Dean Boudoulas, MD, FSCAI, The Ohio State University Wexner Medical Center, Columbus, OH
LAAO’s Underutilized in Cancer Patients
Shruti Singh, MD, The University of Texas Health Science Center at Houston, Houston, TX
“Real-life” Interventional Cardio-oncology
Awad Javaid, MD, The Ohio State University College of Medicine, Columbus, OH